The ‘King Kong of weight loss drugs’ will be available on the NHS but only patients with most need will get it
Mounjaro, known as the “King Kong of weight loss drugs”, will be available to patients on the NHS, but this week it was announced the medication will be prioritised to people with the highest needs – with the rollout expected to extend over 12 years.
We take a look at why the medication is in such demand and the impact it could have on the nation’s health.